Current location:Earthly Echo news portal > world
China's innovative drugs gain momentum in global expansion efforts
Earthly Echo news portal2024-05-21 17:16:28【world】9People have gathered around
Introduction(Xinhua) 16:50, March 18, 2024SHANGHAI, March 18 (Xinhua) -- In November 2023, fruquintinib, a new a
SHANGHAI, March 18 (Xinhua) -- In November 2023, fruquintinib, a new anti-tumor drug developed by Chinese pharmaceutical company HUTCHMED, was approved by the U.S. Food and Drug Administration (FDA) and prescribed in the United States within 48 hours following its approval.
This is the first small-molecule anticancer drug approved in the United States which was developed by a Shanghai pharmaceutical company, and also the first overseas prescription of an innovative drug developed in Shanghai, according to the Science and Technology Commission of Shanghai Municipality.
Fruquintinib, a medicine for the treatment of metastatic colorectal cancer, is among several domestic innovative drugs that were launched in overseas markets in 2023, including Tislelizumab developed by BeiGene and Toripalimab by Junshi Biosciences.
"The year 2023 can be called a milestone year for the overseas launch of domestically produced innovative drugs. Not only did an unprecedented number of drugs go overseas, but also several significant breakthroughs were achieved," said Li Ning, CEO of Junshi Biosciences.
Li added that the increasing share of large molecule drugs, known as biopharmaceuticals, in global markets, as well as the growing number of drugs entering the U.S. market, exemplify these breakthroughs.
The brisk momentum continued into 2024. Chinese pharmaceutical companies forged 18 out-licensing deals in January this year, skyrocketing by 260 percent compared to the same period in 2023.
Chinese innovative drugs have two channels to go global. Some companies independently conduct clinical studies abroad and apply for market approval, eventually gaining authorization to distribute the drugs.
Alternatively, some companies partner with foreign companies to pitch their products overseas, including through out-licensing deals. They sell the rights to commercialize their drugs globally to foreign companies, allowing the latter to take charge of the clinical development, application for market approval, manufacturing and marketing.
Going overseas is no easy task. "The competition for domestically produced innovative drugs to expand overseas is fierce. If you want to penetrate overseas markets, in addition to gaining approval for marketing, you need to achieve commercial success," said Su Weiguo, CEO of HUTCHMED. Under such circumstances, apart from developing high-quality drugs, choosing the right path to enter different markets is crucial, Su added.
In the case of fruquintinib, the drug has chosen to enter a mainstream market with vast demand but meager supply. Su said that the unmet demand of patients in the United States is among the factors contributing to the success of fruquintinib overseas.
"Advanced colorectal cancer is a grave medical challenge. Its global incidence and mortality rates are on the rise, but effective new drugs are not in place. In the United States, the past decade saw not one new drug for treating the disease getting approved," Su said.
Partnering with foreign companies is another path to go overseas, especially for small and medium-sized innovative drug developers. In November 2023, British pharmaceutical company AstraZeneca and Chinese company Eccogene entered into an exclusive license agreement for ECC5004, a glucagon-like peptide 1 receptor agonist discovered by Eccogene for the treatment of obesity, diabetes, and other conditions.
AstraZeneca announced that Shanghai had become the fifth global strategic hub for the company, alongside hubs in the United States, Sweden and Britain, at the 2024 Shanghai Bio-Pharmaceutical Industry International Development Conference held in February.
The British pharmaceutical company also plans to assist 30 Shanghai enterprises to go global in 2024, promoting cross-border cooperation and exchanges in pharmaceutical innovation through two-way visits.
Looking into the future, Chinese innovative drugs can expand beyond the United States and European markets. "We are closely following developments in the Pacific-rim and Indian Ocean-rim markets, and we plan to promote the launch of Chinese innovative drugs in the Republic of Korea (ROK), the Middle East and Southeast Asian countries," Li Ning said.
Address of this article:http://cambodia.barryexit.org/news-66c899866.html
Very good!(4)
Related articles
- Cruise worker 'murders newborn son on board ship': Shocked co
- Eva Mendes gushes over 'my Cuban Papi' Ryan Gosling after he wears T
- Adames powers Brewers past Rays 8
- Rockies become first to team to trail in opening 29 games, waste 5
- Ben Whishaw lights up the Croisette as he joins his co
- Int'l horticultural expo attracts worldwide green fingers to Chengdu
- Blake Lively is seen in first
- Rays and Brewers get into wild brawl, with Uribe and Siri in the middle of it
- Why US Catholics are planning pilgrimages in communities across the nation
- South Korea considers joining alliance for sharing military technology with Australia, US and UK
Popular articles
Recommended
Rangers are undefeated at .500 to keep World Series champs from a losing record with Bochy
New York scores four straight goals to beat Ottawa 4
Blake Lively is seen in first
Ukraine's army chief reports tactical retreat in the east, and warns of front
What a blast to work at NASA. Space agency is sky
DJ Stewart hits a 3
Google and Apple now threatened by the US antitrust laws helped build their technology empires
Police clear pro
Links
- Mexican and Guatemalan presidents meet at border to discuss migration, security and development
- King Charles looks dapper as he attends special gala performance at the Royal Opera House for out
- Kate Garraway shows support for Giovanni Pernice
- Families of Mexican farmworker bus crash victims mourn the loss of their loved ones
- John Daly withdraws from the PGA Championship with a thumb injury
- A man is convicted in Malawi over a TikTok video showing a caricature of the president dancing
- Pride House on Seine River barge is inaugurated by Paris Olympics organizers
- Dallas Wings' Natasha Howard will miss up to 6 weeks after breaking foot in season opener
- Pennsylvania school district's decision to cut song from student concert raises concerns
- Protect yourself from ticks with these tips